Ming Yang
Ming Yang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Zhonghai Li
Department of Orthopedics, First Affiliated Hospital of Dalian Medical University
5 shared publications - Tianze Sun
Department of Trauma and Orthopedics, Peking University People's Hospital, Beijing, 100044, China
3 shared publications - Wentao Zhang
Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian 116600, China
3 shared publications - Yvang Chang
Department of Orthopaedics
3 shared publications Yantao Zhao
Senior Department of Orthopaedics, The Fourth Medical Center of PLA General Hospital, Beijing, China
2 shared publications- Yu Zhang
TheFirst Affiliated Hospital of Weifang Medical College, Weifang 261041, Shandong, China
2 shared publications
Latest Publications
- Open Access
- 22 December 2022
- Published by Elsevier in Materials Today Bio
- Vol. 18, 100528
Construction of artificial periosteum with methacrylamide gelatin hydrogel-wharton's jelly based on stem cell recruitment and its application in bone tissue engineering
- 22 December 2022
- Published by Elsevier in Materials Today Bio
- Vol. 18, 100528
Open AccessConstruction of artificial periosteum with methacrylamide gelatin hydrogel-wharton's jelly based on stem cell recruitment and its application in bone tissue engineering
- Top Cited PapersOpen Access
- 16 February 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 33, 41-54
Periosteum and development of the tissue-engineered periosteum for guided bone regeneration
- 16 February 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 33, 41-54
Top Cited PapersOpen AccessPeriosteum and development of the tissue-engineered periosteum for guided bone regeneration
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
The Dual Effect of Abnormal Serum Uric Acid on Intervertebral Disc Degeneration
An abnormal serum uric acid (SUA) level is associated with many diseases. To our knowledge, there is no research on the association between SUA and intervertebral disc degeneration (IDD). The purpose of this study was to determine the relationship between SUA and IDD. From June 2011 to July 2020, 691 patients undergoing surgery for lumbar disc herniation (LDH) were included in the LDH group, and 684 patients who underwent endoscopic surgery for knee trauma were included in the non‐LDH group. We examined the baseline characteristics of all these patients and divided the SUA level into 10 groups according to the percentiles in males, females, and the total population. Subsequently, the relationship between the SUA level and IDD was further analyzed. There was no statistically significant difference in the baseline characteristics of the two groups (p > 0.05). Among the 10 groups, the LDH rate was higher at both lower and higher SUA levels. In multiple logistic regression analysis, after adjustment for age, sex, body mass index, smoking, and drinking, when the SUA level was 80%, compared with 60–80%, the odds ratio (OR) and 95% confidence interval (CI) of LDH of the total population were 1.821 (1.125–2.946) and 1.701 (1.186–2.438), respectively, and in the males, they were 1.922 (1.169–3.161) and 2.800 (1.766, 4.439), respectively. In females, when the SUA was <20%, there was a higher LDH rate (OR = 1.951, 95% CI 1.091‐3.486). The present study suggests that there is a U‐shaped relationship between SUA and IDD, being particularly prominent among male. Lower and higher SUA level may be risk factors for IDD.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessThe Dual Effect of Abnormal Serum Uric Acid on Intervertebral Disc Degeneration
An abnormal serum uric acid (SUA) level is associated with many diseases. To our knowledge, there is no research on the association between SUA and intervertebral disc degeneration (IDD). The purpose of this study was to determine the relationship between SUA and IDD. From June 2011 to July 2020, 691 patients undergoing surgery for lumbar disc herniation (LDH) were included in the LDH group, and 684 patients who underwent endoscopic surgery for knee trauma were included in the non‐LDH group. We examined the baseline characteristics of all these patients and divided the SUA level into 10 groups according to the percentiles in males, females, and the total population. Subsequently, the relationship between the SUA level and IDD was further analyzed. There was no statistically significant difference in the baseline characteristics of the two groups (p > 0.05). Among the 10 groups, the LDH rate was higher at both lower and higher SUA levels. In multiple logistic regression analysis, after adjustment for age, sex, body mass index, smoking, and drinking, when the SUA level was 80%, compared with 60–80%, the odds ratio (OR) and 95% confidence interval (CI) of LDH of the total population were 1.821 (1.125–2.946) and 1.701 (1.186–2.438), respectively, and in the males, they were 1.922 (1.169–3.161) and 2.800 (1.766, 4.439), respectively. In females, when the SUA was <20%, there was a higher LDH rate (OR = 1.951, 95% CI 1.091‐3.486). The present study suggests that there is a U‐shaped relationship between SUA and IDD, being particularly prominent among male. Lower and higher SUA level may be risk factors for IDD.
- Open Access
- 21 November 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-10
Effect of Platelet-Rich Plasma on Intervertebral Disc Degeneration In Vivo and In Vitro: A Critical Review
Intervertebral disc degeneration (IDD) is a globally occurring disease that represents a significant cause of socioeconomic problems. Currently, the main method for treating IDD is surgery, including discectomy and vertebral fusion. Several in vitro experiments demonstrated that platelet-rich plasma (PRP) could stimulate cell proliferation and extracellular matrix regeneration. Additionally, in vivo experiments have proven that PRP injection could restore intervertebral disc height. Clinical studies demonstrated that PRP injection could significantly relieve patient pain. However, further studies are still required to clarify the roles of PRP in IDD prevention and treatment. This review is aimed at summarizing and critically analyzing the current evidence regarding IDD treatment with PRP.
- 21 November 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-10
Open AccessEffect of Platelet-Rich Plasma on Intervertebral Disc Degeneration In Vivo and In Vitro: A Critical Review
Intervertebral disc degeneration (IDD) is a globally occurring disease that represents a significant cause of socioeconomic problems. Currently, the main method for treating IDD is surgery, including discectomy and vertebral fusion. Several in vitro experiments demonstrated that platelet-rich plasma (PRP) could stimulate cell proliferation and extracellular matrix regeneration. Additionally, in vivo experiments have proven that PRP injection could restore intervertebral disc height. Clinical studies demonstrated that PRP injection could significantly relieve patient pain. However, further studies are still required to clarify the roles of PRP in IDD prevention and treatment. This review is aimed at summarizing and critically analyzing the current evidence regarding IDD treatment with PRP.
- 1 July 2020
- Published by Elsevier in Medical Hypotheses
- Vol. 140, 109673
Does hyperuricemia correlate with intervertebral disc degeneration?
- 1 July 2020
- Published by Elsevier in Medical Hypotheses
- Vol. 140, 109673
Does hyperuricemia correlate with intervertebral disc degeneration?